Melflufen Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Melflufen Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma: Long-Term Survival Follow-Up From the Phase II Study O-12-M1
Br. J. Haematol 2021 Jan 06;[EPub Ahead of Print], S Bringhen, PM Voorhees, T Plesner, UH Mellqvist, B Reeves, P Sonneveld, C Byrne, E Nordström, J Harmenberg, J Obermüller, PG RichardsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.